← Leaderboards
Meryl Waldman
National Institute Of Diabetes And Digestive And Kidney Diseases
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute Of Diabetes And Digestive And Kidney Diseases
Same institution · by research overlap
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsDisease RemissionMembranous GlomerulonephritisKidney DiseasesProtocols DocumentationMediatingProgramsImmuneBenefits And RisksAntibodiesClinical CareCyclosporineEnrollmentDoseIntravenousEffectiveness EvaluationEffectivenessB-LymphocytesDyslipidemiasEvolutionFutureIdiopathic Membranous NephropathyComplementBelimumab
Grant awards (5)
Studies of Immunologically-Mediated Kidney Diseases$527,238
ZIA · FY2025 · DK · contact PI
Treatment trials- Rituximab plus cyclosporine for MN and Belimumab plus rituximab for MN (REBOOT)$218,427
ZIA · FY2025 · DK · contact PI
Apellis RWD (Retro) Protocol$7,532
ZIA · FY2025 · DK · contact PI
Studies of Immunologically-Mediated Kidney Diseases$635,974
ZIA · FY2024 · DK · contact PI
Treatment trials- Rituximab plus cyclosporine for MN and Belimumab plus rituximab for MN (REBOOT)$272,560
ZIA · FY2024 · DK · contact PI